Phibro Animal Health (PAHC) Total Non-Current Liabilities (2013 - 2026)
Phibro Animal Health (PAHC) posted Total Non-Current Liabilities of $1.0 billion for Q2 2026, up 2.98% on a QoQ basis from $994.6 million in Q1 2026, and up 2.84% year-over-year from $995.9 million in Q2 2025.
Analysis
Phibro Animal Health (PAHC) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends
Phibro Animal Health has reported Total Non-Current Liabilities for 14 years, with the latest figure at $1.0 billion in Q2 2026.
- On a quarterly basis, Total Non-Current Liabilities rose 2.84% year-over-year to $1.0 billion in Q2 2026; TTM through Jun 2026 was $1.0 billion, a 2.84% increase from a year earlier, with the FY2026 full-year figure at $1.0 billion, up 2.84% from the prior year.
- Total Non-Current Liabilities was $1.0 billion for Q2 2026 at Phibro Animal Health, up from $994.6 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $1.0 billion in Q2 2026, with the low at $587.7 million in Q1 2022.
- Average Total Non-Current Liabilities over 5 years is $771.0 million, with a median of $644.3 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2025: Total Non-Current Liabilities grew 1.09% in 2023, then soared 54.55% in 2025.
- Over 5 years, Total Non-Current Liabilities stood at $628.4 million in 2022, then rose by 1.31% to $636.6 million in 2023, then surged by 52.4% to $970.1 million in 2024, then grew by 2.35% to $993.0 million in 2025, then gained by 3.15% to $1.0 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $1.0 billion (Q2 2026), $994.6 million (Q1 2026), and $993.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 542.10 Mn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | 11.64 Bn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 6.42 Bn |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 1.02 Bn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | 10.82 Mn |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | 1.31 Mn |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.02 Bn |
| Mar 31, 2026 | 994.56 Mn |
| Dec 31, 2025 | 992.97 Mn |
| Sep 30, 2025 | 994.66 Mn |
| Jun 30, 2025 | 995.91 Mn |
| Mar 31, 2025 | 977.64 Mn |
| Dec 31, 2024 | 970.13 Mn |
| Sep 30, 2024 | 643.56 Mn |
| Jun 30, 2024 | 662.44 Mn |
| Mar 31, 2024 | 645.08 Mn |
| Dec 31, 2023 | 636.59 Mn |
| Sep 30, 2023 | 631.07 Mn |
| Jun 30, 2023 | 628.54 Mn |
| Mar 31, 2023 | 631.32 Mn |
| Dec 31, 2022 | 628.38 Mn |
| Sep 30, 2022 | 624.24 Mn |
| Jun 30, 2022 | 608.76 Mn |
| Mar 31, 2022 | 587.72 Mn |
| Dec 31, 2021 | 553.95 Mn |
| Sep 30, 2021 | 546.60 Mn |